Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ADTX - announces they are buying a company developing a covid pill in Europe…. are they buying AEZS?
Heeeellooo!?
https://seekingalpha.com/instablog/50857529-johnsoriaknows/5629528-aezs-developing-game-changing-covidminus-19-orally-available-vaccine-while-diversifying
Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA
May 03 2021 - 02:15PM
PR Newswire (US)
MOUNTAIN VIEW, Calif. and RICHMOND, Va., May 3, 2021 /PRNewswire/ -- Aditxt (Aditx Therapeutics, Inc.) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced plans to build a high-capacity AditxtScore™ Center in Richmond, VA in the second half of 2021. Aditxt is targeting a capital investment of $31.5 million over three years to scale up its state-of-the-art immune monitoring center, including projected new jobs, laboratory equipment, and construction. The announcement was made at a joint press conference with Governor Ralph Northam, Richmond Mayor Levar Stoney and other local business executives and political officials.
(PRNewsfoto/Aditxt)
The new immune monitoring center is being developed to increase processing capacity for the company's flagship AditxtScore™, a pioneering new approach to immune health monitoring that provides a comprehensive profile of the immune system. By assessing an individual's immune biomarkers, AditxtScore™ will be able to measure indications of immunity to specific disease. AditxtScore™ applications include the recently commercialized AditxtScore™ for COVID-19, developed for use in detecting antibodies and neutralizing antibodies against SARS-CoV-2 antigens. Other applications under development include, among others, predicting dynamic monitoring of the immune system in infectious and autoimmune diseases, organ transplantation, and allergy.
Amro Albanna, co-founder and CEO of Aditxt, commented, "Richmond is an ideal location for our first high-capacity AditxtScore Center given its skilled workforce, location, and infrastructure. As we begin rolling out the AditxtScore platform and applications for immune monitoring, the establishment of an AditxtScore Immune Monitoring Network is vital to realizing our full vision for AditxtScore, which is to transform how we monitor the immune system from reactive testing to proactive monitoring. We look forward to working with the community to complete this important step in the execution of Aditxt's strategic plan, and we are grateful to the Commonwealth of Virginia, Governor Northam, his team, and all involved for their support and welcoming reception."
Aditxt expects to create more than 300 new jobs over the next three years to increase AditxtScore™ processing capacity up to a projected 10 million reports annually in efforts to provide more access to individuals to monitor and understand their immune profiles. The company will occupy 25,000 square feet of BioTech 8 in the Virginia Bio+Tech Park, a campus of Activation Capital, with plans for future expansion.
"The Richmond region has emerged as a hub for cutting-edge biotech companies, and this thriving industry will be bolstered by the addition of Aditxt's Immune Monitoring Center," said Governor Northam. "The Virginia Bio+Tech Park is an ideal location for the company to continue its groundbreaking work to improve the health of our communities and help us better understand our own immune systems—something that has become extremely important over the past year. We are honored to welcome Aditxt to the Commonwealth, and we thank the company for creating more than 300 well-paid jobs for the people of Virginia."
Support for Aditxt's job creation will be provided through the Virginia Talent Accelerator Program, a workforce initiative created by VEDP in collaboration with the Virginia Community College System and other higher education partners, with funding support from the Northam Administration and the Virginia General Assembly. Launched in 2019, the program accelerates new facility start-ups through the direct delivery of recruitment and training services that are fully customized to a company's unique products, processes, equipment, standards, and culture. All program services are provided at no cost to qualified new and expanding companies as an incentive for job creation.
About Aditx Therapeutics
Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visit: www.aditxt.com
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of federal securities laws. Forward looking statements include statements regarding the Company's intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company's ongoing and planned product and business development; the Company's intellectual property position; the Company's ability to develop commercial functions; expectations regarding product launch and revenue; the Company's results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section titled "Risk Factors" in the Company's most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company's other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/aditxt-to-establish-state-of-the-art-immune-monitoring-center-in-richmond-va-301282382.html
SOURCE Aditxt
Copyright 2021 PR Newswire
* * $ADTX Video Chart 02-11-2021 * *
Link to Video - click here to watch the technical chart video
* * $ADTX Video Chart 01-21-2021 * *
Link to Video - click here to watch the technical chart video
What an amazing start to this game changing year Golden choo-choo;)
Amazing and congratz>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
I think shorts may do their job here. News IS very good, so we’ll see. I personally have exited all positions for my 2nd trade of day. If it keeps beasting I’ll jump back in. Do not go by my words. All imo..
you nailed that timeline perfectly. now, is the news good enough to take it higher is my question?
Yeah. I am holding here. still looking for 5 by the eod.
Shorts are having a good time right now. In another hour or 2 it should surge back up again...hitting 5’s again imo
Buying right here 4.05 come on now lets get back to 5
In the words of Forrest Gump ADTX be running!!!!!
Luv it Golden buddy! What a 1st Quarter we're in for on multiple plays right cheers>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Get in today p/m breakouts today
The OTC's been so sizzlin' HOT I haven't been able to post on my OTC plays let alone respond to all my private and public messages sorry ace buddy, but you know I still luv this stock ok cheers!
Blue skies looks like
Excellent ace, gotta trade these bad boys when they're providing us opportunity to do so right kudos!
Bought back in 2.00$ this is fun :)
I guess they didn’t get the approval?????
OMG time almost upon us right ace buddy!
Awaiting news perfect time cmon fda lol
GM power buddy excellent! We're lookin' gooooooood!
More to come tomorrow :D
Well we meet again bud. I grab a few today.
Volume very bullish Chart ~> https://stockcharts.com/h-sc/ui?s=Adtx
Yep ace and the market clearly agrees with you>>>$$$$$$$$$$$$$$$$$$$$$$$$$
Big move coming anyday
Can't wait ace, release this BEAST right cheers!
we are awaiting a response from the U.S. Food and Drug Administration regarding the Emergency Use Authorization (EUA) application that we filed in August.
350k buys in seconds some ones buying them up
Agreed buddy! Gotta be in em to win em right glty!
Adtx is covid related gonna be a big runner soon
Agreed buddy! And with the markets being such an insane whirlwind since ROCKTOBER madness began, I honestly appreciate your reminder here, because it's next to impossible to keep track of all the insane OTC movers and big board bank makers out there these days right cheers:)
Anytime 50ma break huge ! https://stockcharts.com/h-sc/ui?s=Adtx
Thank you ace! Glad you thought of me, it's greatly appreciated!
$GLSI 129.93 +2399% somebody call the SEC Police
Tuesday dec 15th presentation ~> (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Tuesday, December 15, 2020 at 11:00 AM EST / 8:00 AM PST. Amro Albanna, Co-founder and Chief Executive Officer of Aditxt, will be presenting to a live, virtual audience.
Would be nice. Too many forces
Nice catch thanks SM, boomin' nicely so far too woot-woot!
yup .... watching for entry ...
Followers
|
25
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
477
|
Created
|
08/06/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |